Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$134.93−2.95 (-2.14%)
Close on Nov 18, 2026Market cap $13.31BP/E 22.0Yield 0.53%
Encompass Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Encompass Health's free cash flow for the twelve months ending Jun 30, 2026 was $413.40M, down 5.9% year over year. For fiscal 2025 it was $439.20M, up 21.9% from the year before. Over ten years it grew 1.6% a year on average. The highest annual figure on record is $507.90M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $439.20M | +21.9% |
| FY2024 | Dec 31, 2024 | $360.30M | +34.6% |
| FY2023 | Dec 31, 2023 | $267.70M | +120.0% |
| FY2022 | Dec 31, 2022 | $121.70M | -28.5% |
| FY2021 | Dec 31, 2021 | $170.10M | -45.5% |
| FY2020 | Dec 31, 2020 | $311.90M | +18.6% |
| FY2019 | Dec 31, 2019 | $262.90M | -48.2% |
| FY2018 | Dec 31, 2018 | $507.90M | +17.4% |
| FY2017 | Dec 31, 2017 | $432.50M | -6.5% |
| FY2016 | Dec 31, 2016 | $462.50M | +23.8% |
| FY2015 | Dec 31, 2015 | $373.60M | +36.4% |
| FY2014 | Dec 31, 2014 | $274.00M | -0.4% |
| FY2013 | Dec 31, 2013 | $275.10M | +1.6% |
| FY2012 | Dec 31, 2012 | $270.70M | +11.7% |
| FY2011 | Dec 31, 2011 | $242.40M | -9.6% |
| FY2010 | Dec 31, 2010 | $268.20M | -21.8% |
| FY2009 | Dec 31, 2009 | $342.80M | +99.9% |
| FY2008 | Dec 31, 2008 | $171.50M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $62.30M | -45.0% |
| Q1 FY2026 | Mar 31, 2026 | $150.70M | +20.1% |
| Q4 FY2025 | Dec 31, 2025 | $116.70M | +45.7% |
| Q3 FY2025 | Sep 30, 2025 | $83.70M | -30.4% |
| Q2 FY2025 | Jun 30, 2025 | $113.30M | +87.3% |
| Q1 FY2025 | Mar 31, 2025 | $125.50M | +26.3% |
| Q4 FY2024 | Dec 31, 2024 | $80.10M | – |
| Q3 FY2024 | Sep 30, 2024 | $120.30M | +83.7% |
| Q2 FY2024 | Jun 30, 2024 | $60.50M | -28.7% |
| Q1 FY2024 | Mar 31, 2024 | $99.40M | -22.4% |
| Q4 FY2023 | Dec 31, 2023 | -$10.70M | – |
| Q3 FY2023 | Sep 30, 2023 | $65.50M | – |
| Q2 FY2023 | Jun 30, 2023 | $84.80M | -35.7% |
| Q1 FY2023 | Mar 31, 2023 | $128.10M | +20.8% |
| Q4 FY2022 | Dec 31, 2022 | -$37.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$79.20M | -236.6% |
| Q2 FY2022 | Jun 30, 2022 | $131.90M | -7.1% |
| Q1 FY2022 | Mar 31, 2022 | $106.00M | +77.6% |
| Q4 FY2021 | Dec 31, 2021 | -$89.60M | -162.6% |
| Q3 FY2021 | Sep 30, 2021 | $58.00M | -30.8% |
| Q2 FY2021 | Jun 30, 2021 | $142.00M | +2.0% |
| Q1 FY2021 | Mar 31, 2021 | $59.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $143.10M | +38.8% |
| Q3 FY2020 | Sep 30, 2020 | $83.80M | +713.6% |
| Q2 FY2020 | Jun 30, 2020 | $139.20M | +124.9% |
| Q1 FY2020 | Mar 31, 2020 | -$54.20M | -161.9% |
| Q4 FY2019 | Dec 31, 2019 | $103.10M | +8.1% |
| Q3 FY2019 | Sep 30, 2019 | $10.30M | -92.4% |
| Q2 FY2019 | Jun 30, 2019 | $61.90M | -48.5% |
| Q1 FY2019 | Mar 31, 2019 | $87.60M | -44.0% |
| Q4 FY2018 | Dec 31, 2018 | $95.40M | +17.3% |
| Q3 FY2018 | Sep 30, 2018 | $135.80M | +14.0% |
| Q2 FY2018 | Jun 30, 2018 | $120.30M | +30.1% |
| Q1 FY2018 | Mar 31, 2018 | $156.40M | +12.0% |
| Q4 FY2017 | Dec 31, 2017 | $81.30M | +5.6% |
| Q3 FY2017 | Sep 30, 2017 | $119.10M | -11.8% |
| Q2 FY2017 | Jun 30, 2017 | $92.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $139.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $77.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $135.10M | – |
See a number that looks wrong?